- Home
- CTRM vs PRPO Comparison
CTRM vs PRPO Comparison
Compare CTRM & PRPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTRM
- PRPO
- Stock Information
- Founded
- CTRM 2016
- PRPO N/A
- Country
- CTRM Cyprus
- PRPO United States
- Employees
- CTRM N/A
- PRPO N/A
- Industry
- CTRM Marine Transportation
- PRPO Biotechnology: Laboratory Analytical Instruments
- Sector
- CTRM Consumer Discretionary
- PRPO Industrials
- Exchange
- CTRM Nasdaq
- PRPO Nasdaq
- Market Cap
- CTRM 21.2M
- PRPO 22.0M
- IPO Year
- CTRM N/A
- PRPO N/A
- Fundamental
- Price
- CTRM $2.11
- PRPO $19.20
- Analyst Decision
- CTRM
- PRPO
- Analyst Count
- CTRM 0
- PRPO 0
- Target Price
- CTRM N/A
- PRPO N/A
- AVG Volume (30 Days)
- CTRM 39.8K
- PRPO 17.6K
- Earning Date
- CTRM 11-06-2025
- PRPO 11-05-2025
- Dividend Yield
- CTRM N/A
- PRPO N/A
- EPS Growth
- CTRM N/A
- PRPO N/A
- EPS
- CTRM N/A
- PRPO N/A
- Revenue
- CTRM $67,859,415.00
- PRPO $21,242,000.00
- Revenue This Year
- CTRM N/A
- PRPO N/A
- Revenue Next Year
- CTRM N/A
- PRPO N/A
- P/E Ratio
- CTRM N/A
- PRPO N/A
- Revenue Growth
- CTRM N/A
- PRPO 27.05
- 52 Week Low
- CTRM $1.91
- PRPO $3.90
- 52 Week High
- CTRM $4.19
- PRPO $22.38
- Technical
- Relative Strength Index (RSI)
- CTRM 48.73
- PRPO 58.88
- Support Level
- CTRM $2.11
- PRPO $16.50
- Resistance Level
- CTRM $2.22
- PRPO $21.23
- Average True Range (ATR)
- CTRM 0.06
- PRPO 1.41
- MACD
- CTRM 0.00
- PRPO 0.12
- Stochastic Oscillator
- CTRM 33.71
- PRPO 61.02
About CTRM Castor Maritime Inc.
Castor Maritime Inc is a provider of seaborne transportation services for dry bulk cargo, including iron ore, coal, grain, steel products, fertilizers, cement, bauxite, sugar, and scrap metal, among others. The firm operates under three reportable segments namely (i) the dry bulk segment (ii) the containership segment and (iii) the asset management segment. It generates maximum revenue from the Dry bulk segment.
About PRPO Precipio Inc.
Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents, and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.